PMID- 19553558 OWN - NLM STAT- MEDLINE DCOM- 20090928 LR - 20211020 IS - 1556-679X (Electronic) IS - 1556-6811 (Print) IS - 1556-679X (Linking) VI - 16 IP - 8 DP - 2009 Aug TI - Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia. PG - 1146-50 LID - 10.1128/CVI.00105-09 [doi] AB - Human leukocyte antigen (HLA) class II genes contribute to the genetic susceptibility to type 1 diabetes (T1D), and susceptible alleles and haplotypes were implicated in the pathogenesis of T1D. This study investigated the heterogeneity in HLA class II haplotype distribution among Tunisian patients with T1D. This was a retrospective case control study done in Monastir in central Tunisia. The subjects comprised 88 T1D patients and 112 healthy controls. HLA-DRB1 and -DQB1 genotyping was done by PCR-sequence-specific priming. Significant DRB1 and DQB1 allelic differences were seen between T1D patients and controls; these differences comprised DRB1*030101 and DQB1*0302, which were higher in T1D patients than in control subjects, and DRB1*070101, DRB1*110101, DQB1*030101, and DQB1*060101, which were lower in T1D patients than in control subjects. In addition, the frequencies of DRB1*030101-DQB1*0201 and DRB1*040101-DQB1*0302 were higher in T1D patients than in control subjects, and the frequencies of DRB1*070101-DQB1*0201 and DRB1*110101-DQB1*030101 haplotypes were lower in T1D patients than in control subjects. Multiple logistic regression analysis revealed the positive association of DRB1*030101-DQB1*0201 and DRB1*040101-DQB1*0302 and the negative association of only DRB1*070101-DQB1*0201 haplotypes with T1D. Furthermore, a significantly increased prevalence of DRB1*030101-DQB1*0201 homozygotes was seen for T1D subjects than for control subjects. Our results confirm the association of specific HLA-DR and -DQ alleles and haplotypes with T1D in Tunisians. The identification of similar and unique haplotypes in Tunisians compared to other Caucasians highlights the need for evaluating the contribution of HLA class II to the genetic susceptibility to T1D with regard to haplotype usage and also to ethnic origin and racial background. FAU - Stayoussef, Mouna AU - Stayoussef M AD - Research Unit of Hematological and Autoimmune Diseases, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia. FAU - Benmansour, Jihen AU - Benmansour J FAU - Al-Irhayim, Abdul-Qader AU - Al-Irhayim AQ FAU - Said, Hichem B AU - Said HB FAU - Rayana, Chiheb B AU - Rayana CB FAU - Mahjoub, Touhami AU - Mahjoub T FAU - Almawi, Wassim Y AU - Almawi WY LA - eng PT - Journal Article DEP - 20090624 PL - United States TA - Clin Vaccine Immunol JT - Clinical and vaccine immunology : CVI JID - 101252125 RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DQB1 antigen) RN - 0 (HLA-DR Antigens) RN - 0 (HLA-DRB1 Chains) RN - 0 (HLA-DRB1*11:01:01 antigen) SB - IM MH - Adolescent MH - Adult MH - Case-Control Studies MH - Child MH - Diabetes Mellitus, Type 1/*epidemiology/*genetics/immunology MH - Female MH - Gene Frequency MH - *Genetic Predisposition to Disease MH - HLA-DQ Antigens/*genetics MH - HLA-DQ beta-Chains MH - HLA-DR Antigens/*genetics MH - HLA-DRB1 Chains MH - Haplotypes MH - Humans MH - Male MH - Polymerase Chain Reaction/methods MH - *Polymorphism, Genetic MH - Retrospective Studies MH - Sequence Analysis, DNA/methods MH - Tunisia/epidemiology MH - Young Adult PMC - PMC2725529 EDAT- 2009/06/26 09:00 MHDA- 2009/09/29 06:00 PMCR- 2010/02/01 CRDT- 2009/06/26 09:00 PHST- 2009/06/26 09:00 [entrez] PHST- 2009/06/26 09:00 [pubmed] PHST- 2009/09/29 06:00 [medline] PHST- 2010/02/01 00:00 [pmc-release] AID - CVI.00105-09 [pii] AID - 0105-09 [pii] AID - 10.1128/CVI.00105-09 [doi] PST - ppublish SO - Clin Vaccine Immunol. 2009 Aug;16(8):1146-50. doi: 10.1128/CVI.00105-09. Epub 2009 Jun 24.